Cite

HARVARD Citation

    Ramachandran, B. et al. (2016). Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia. Toxicology reports. pp. 336-345. [Online]. 
  
Back to record